VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 378 filers reported holding VANECK VECTORS ETF TR in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $648,000 | -25.7% | 30,732 | -34.8% | 0.01% | -15.4% |
| Q3 2018 | $872,000 | -21.7% | 47,106 | -5.5% | 0.01% | -31.6% |
| Q2 2018 | $1,113,000 | -3.0% | 49,868 | -4.4% | 0.02% | -5.0% |
| Q1 2018 | $1,147,000 | +4.6% | 52,176 | +10.5% | 0.02% | -4.8% |
| Q4 2017 | $1,097,000 | -10.7% | 47,216 | -11.8% | 0.02% | -12.5% |
| Q3 2017 | $1,229,000 | -23.3% | 53,508 | -26.3% | 0.02% | -25.0% |
| Q2 2017 | $1,603,000 | +6.0% | 72,609 | +9.6% | 0.03% | +3.2% |
| Q1 2017 | $1,512,000 | +60.3% | 66,266 | +47.1% | 0.03% | +55.0% |
| Q4 2016 | $943,000 | +277.2% | 45,055 | +376.8% | 0.02% | +233.3% |
| Q3 2016 | $250,000 | +8.7% | 9,450 | +13.9% | 0.01% | +20.0% |
| Q2 2016 | $230,000 | – | 8,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |